ChemicalBook--->CAS DataBase List--->134235-09-9

134235-09-9

134235-09-9 Structure

134235-09-9 Structure
IdentificationBack Directory
[Name]

Cyclobutanecarboxylic acid, 3-ethylidene-2-methyl-, methyl ester, [1S-
[CAS]

134235-09-9
[Synonyms]

Cyclobutanecarboxylic acid, 3-ethylidene-2-methyl-, methyl ester, [1S-
Cyclobutanecarboxylic acid, 3-ethylidene-2-methyl-, methyl ester, [1S-(1α,2α,3Z)]- (9CI)
[Molecular Formula]

C9H14O2
[MOL File]

134235-09-9.mol
[Molecular Weight]

154.21
Hazard InformationBack Directory
[Definition]

ChEBI: Paromomycin is an amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. It has a role as an antibacterial drug, an antiprotozoal drug, an anthelminthic drug and an antiparasitic agent. It is an aminoglycoside antibiotic and an amino cyclitol glycoside. It is functionally related to a streptamine.
134235-09-9 suppliers list
Tags:134235-09-9 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.